Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12622000398707Phase 4Completed
Phase 4, open-label trial of enalapril in hypertension (HTN) (2 arms), sponsored by High Blood Pressure Research Council of Australia. Primary endpoint: Composite primary outcome: all-cause mortality and cardiovascular events. Started Jul 1996; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12622000398707.